OIG ISSUES FINAL PHARMA GUIDANCE

At press time, the Office of Inspector General issued its final compliance program guidance for pharmaceutical manufacturers, available at www.oig.hhs.gov.

The guidance has major implications for CME providers. It underscores that commercial supporters must not have influence over content or faculty of CME. It also says “codes of conduct promulgated by the CME industry may provide a useful starting point for manufacturers when revie

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Already a member? .

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish